Pregled bibliografske jedinice broj: 656648
Trace elements and inflammatory and oxidative markers in hemodialysis patients
Trace elements and inflammatory and oxidative markers in hemodialysis patients // X ISTERH Conference Trace Element Research on Health and Diseases ; u: Journal of Trace Elements in Medicine and Biology 27 (2013) (S1)
Tokyo, Japan, 2013. str. 40-40 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 656648 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Trace elements and inflammatory and oxidative markers in hemodialysis patients
Autori
Jurasović, Jasna ; Mujagić, Renat ; Sekovanić, Ankica ; Vrkić, Nada ; Orct, Tatjana
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
X ISTERH Conference Trace Element Research on Health and Diseases ; u: Journal of Trace Elements in Medicine and Biology 27 (2013) (S1)
/ - , 2013, 40-40
Skup
ISTERH Conference "Trace Element Research on Health and Diseases" (10 ; 2013)
Mjesto i datum
Tokyo, Japan, 18.11.2013. - 22.11.2013
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
biomarkers; essentail elements; chronic hemodyalisis patients; inflammation; oxidatative stress
Sažetak
Oxidative stress, inflammation and trace element imbalance occur in most hemodialysis (HD) patients. In order to test trace element status and the possible influence of inflammatory state and oxidative stress in HD patients on biomarkers in plasma and erythrocytes, we assessed related parameters in 100 HD patients. They included: Fe, Cu, Zn, and Se levels in plasma and erythrocytes, total and non-transferrin Fe, ferritin, C- reactive protein, albumin/globulin, ceruloplasmin, protein carbonylation and superoxide dismutase. Plasma Fe and Cu markers were clearly affected by inflammatory state and oxidative stress, while erythrocyte concentrations remained unaffected. HD patients showed Zn and Se deficiency and apparently normal Fe and Cu plasma levels. In HD patients, Fe and Cu plasma level was not a reliable marker of body status. Using erythrocytes as a marker of trace element status should be evaluated, especially in relation to the role of Fe (indirectly of Cu, as well) for efficient anemia treatment in HD patients.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti, Javno zdravstvo i zdravstvena zaštita, Farmacija
POVEZANOST RADA
Projekti:
022-0222148-2135 - Izloženost metalima i njihovi učinci u graviditetu i postnatalnom razdoblju (Piasek, Martina, MZOS ) ( CroRIS)
134-0061245-0205 - Hemoreološki poremećaji u kroničnim bolestima (Vrkić, Nada, MZOS ) ( CroRIS)
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Institut za medicinska istraživanja i medicinu rada, Zagreb,
KBC "Sestre Milosrdnice"
Profili:
Renat Mujagić
(autor)
Ankica Sekovanić
(autor)
Nada Vrkić
(autor)
Tatjana Orct
(autor)
Jasna Jurasović
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE